Presentation synopsis:

 The role of ES in HIV, HCV and TB research in Central East and Eastern Europe

EuroSIDA is the only cohort of people living with HIV (PLHIV) that includes participants from all over Europe, including the Eastern part of the continent. Initiated back in 1994, it has been a pioneer in establishing HIV research in Central and Eastern Europe, thus having a unique opportunity of analyzing clinical and epidemiological aspects of the HIV epidemic in these regions, including post-Soviet countries. EuroSIDA has been at the forefront of showing the now well-known regional differences in the HIV epidemic across Europe, with a continued poorer outcome for PLHIV in Eastern Europe, as well as documenting high prevalence of HCV coinfection and warning about TB epidemic among PLHIV in the region. Results from the EuroSIDA study have contributed in attracting public and political attention on the critical situation in the region in terms of HIV/HCV and TB coinfections. Strengthening and expanding collaboration with Eastern European colleagues remains a major goal of the EuroSIDA study and has already resulted in several additional projects concerning HIV, HCV and TB epidemics.

Speaker biography:

Daria Podlekareva, MD, PhD is a medical doctor at the Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark. She is also affiliated senior researcher at the Centre of Excellence for Health, Immunity and Infections (CHIP) at the same hospital. Daria started her research career back in 2004 when she joined EuroSIDA study at CHIP as a PhD student. Her research is dedicated to HIV epidemic in the Eastern European region, with a particular focus on coinfection with tuberculosis (TB).  Daria’s Belarussian origin has allowed her to understand the set-up of health systems in Eastern Europe as well as the special challenges in this region, where the prevalence of TB is high.

Daria was responsible in expanding EuroSIDA study in post-Soviet countries, and later, she played a central role in the development and coordination of the cohort study dedicated to the management of HIV/TB coinfected individuals (TB: HIV study). A solid and fruitful collaboration with clinicians from nearly 30 HIV and TB clinics has been established and resulted in numerous publications characterising HIV and TB epidemics, management and outcomes of coinfected patients in Eastern Europe, as well as benchmarking of HIV/TB healthcare.


Registration is open

Second Announcement

Take a look

Call for abstracts

Submissions are closed